Connect with us

Cannabis News

GOP Senator To File Bill Promoting Psychedelics Research And Treatment For Veterans

Published

on

A new Senate bill is being introduced that would encourage research into the therapeutic potential of psychedelics, create a new office at the Department of Veterans Affairs (VA) to develop innovative treatments for serious mental health illnesses, and help review the scheduling status of drugs like psilocybin, ibogaine and MDMA.

The legislation, titled the “Veterans Health Administration New Therapeutics Training Act,” is sponsored by Senator Tim Sheehy (R-MT). According to bill text obtained by Marijuana Moment, it would direct the VA to take steps to ease studies on psychedelics and other emerging therapies.

This is one of the latest examples of Congressional efforts to encourage scientific research on psychedelics, focusing on military veterans with conditions such as post-traumatic stress disorder (PTSD), treatment-resistant depression, substance use disorder, traumatic brain injury (TBI), chronic pain, and more.

The bill is expected to be formally introduced on Wednesday, according to a source familiar with the planning. Marijuana Moment reached out to Sheehy’s office for comment, but a representative was not immediately available.

“Ongoing therapeutic interventions, including some psychedelic-assisted therapies, that have been evaluated by the Food and Drug Administration since the enactment of this Act could significantly change the landscape of treatment for post-traumatic stress disorder, depression, and other mental health conditions affecting veterans,” the bill finds.

“The administration of certain emerging therapies may require intensive clinical engagement, interdisciplinary teams, dedicated clinical space, structured preparation and post-treatment integration that differ significantly from traditional outpatient mental health services,” he continues, adding that the VA is “uniquely positioned to provide comprehensive veteran-centered care that combines mental health, medical health services and support into a single system.”

That’s the only explicit mention of “psychedelics” in the legislation, and it doesn’t list the specific psychedelic substances that would be prioritized for research, but that’s a common feature of recent bills on the subject, with many other examples using catchy terminology, such as innovative or novel treatments or therapies that effectively serve as “substitutes for psychedelics.”

The measure would establish a new Office of New Therapeutics under the Veterans Health Administration (VHA) to facilitate research initiatives. Studies examining alternative treatments would focus on substances such as psychedelics that are being considered for approval by the Food and Drug Administration (FDA).

“In the absence of centralized governance and implementation planning, the Department may experience delays, safety risks, or inconsistent access following regulatory approval of these therapies,” the bill’s findings section says. “Establishing a dedicated Office of New Therapeutics will enable the Department to proactively evaluate, research and implement emerging treatment modalities consistent with patient safety and evidence-based practice.”

There would be at least one “Center of Excellence” in each VA regional district to help develop a national model for the program facilitation initiative. A Veterans Advisory Board, made up of veterans, experts and health professionals, would be created to advise on issues such as access barriers and safety protocols.

VA should also coordinate with other federal agencies—including the US Department of Health and Human Services (HHS), FDA, Centers for Medicaid and Medicare Services (CMS), Department of Defense (DOD), and Drug Enforcement Administration (DEA)—to explore regulatory issues, possible rescheduling action for new therapies, and resources to provide psychiatric health care access and treatment.

The VA should provide annual reports to Congress to update lawmakers on its progress. Within 180 days of the bill’s passage, the department would have to report on practical issues, such as staffing needs and regulatory hurdles.

The bill is somewhat Similar intent to another bipartisan measure introduced earlier this monthSponsored by Senators Ruben Gallego (D-AZ) and David McCormick (R-PA), it would provide $30 million in annual funding to establish psychedelic-focused “centers of excellence” at VA facilities where veterans can receive innovative treatments involving substances such as psilocybin, MDMA and ibogaine.

Supplemental version of the house bill—Sponsored by the Chair of the Congressional Psychedelics Advancing Therapies (PATH) Caucus Reps. Lou Correa (D-CA) and Jack Bergman (R-MI)—were introduced last year, but have yet to advance in the House. The measures of the House and Senate are very similar, with minor format differences.

Lawmakers and advocates supporting those reform bills have allies in senior Trump administration positions, including VA Secretary Doug Collins and Robert F. Kennedy, Jr. Secretary of HHS, both of whom have endorsed psychedelic policy reform.

Kennedy recently told Joe Rogan on a podcast episode The administration is “very keen” to create a pathway for novel therapies and that federal agency officials want to “get the public up to speed as quickly as possible.”

Multiple veterans groups also recently advised lawmakers in Congress about the need continue to explore psychedelics and marijuana as alternative treatments At hearings on Capitol Hill for the military veteran population. The Wounded Warrior Project (WWP) and Veterans of Foreign Wars (VFW) specifically cited the Innovative Therapy Centers of Excellence Act as an example of a reform they are supporting.

Correa and Bergman, the sponsors of this legislation, submitted separately in January also to promote research into the therapeutic potential of certain psychedelics in the treatment of serious mental health conditions experienced by veterans.

January’s bipartisan pair also discussed it the importance of strategically advancing psychedelic reform in a way that mitigates bureaucratic conflict and the influence of external interests. They said even a single mistake could threaten to turn the movement upside down.

Last year, VA Secretary He proclaimed his mission to promote access to psychedelics for veterans with serious mental health conditions, it was possible to say that it “opened that door wider than most probably thought”. The department came under fire in 2024 after rejecting an organization’s grant application It helps connect veterans to programs overseas where they can receive psychedelic therapy to treat serious mental health conditions.

Meanwhile, in November, Kennedy, Vice President JD Vance, FDA Commissioner and other Trump administration officials attended the “Make America Healthy Again” summit. it was a session dedicated to studying psychedelic medicine.

In June, Kennedy said that his agency “Fully committed” to expanding research into the benefits of psychedelic therapy. and, along with the head of the FDA, aims to give military veterans legal access to these substances “within 12 months.”

The secretary also said that in April He had a “wonderful experience” with LSD at the age of 15He took it because he thought they would be able to see dinosaurs, as depicted in a comic he was a fan of.

Last October, Kennedy specifically criticized the FDA under the previous administration for the agency’s “eradication of psychedelics” and a laundry list of other issues that he said was a “war on public health” that would end under the Trump administration.

read it the text Under the Veterans Health Administration’s New Therapeutics Training Act:

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Cannabis News

UFCW Local 27 files federal unfair labor practice charges against The Apothecarium, TerrAscend

Published

on

By

UFCW Local 27 filed unfair labor practice charges with the National Labor Relations Board on May 1 against Apothecarium Dispensary in Salisbury and TerrAscend Corp. against the parent company.

The charges stem from an incident in which an assistant general manager removed union cookies from an employee bulletin board, materials that are protected under federal law. Employees have a legally guaranteed right to organize, communicate and distribute union information in designated workplace areas. Impeding these rights is a direct violation of the National Labor Relations Act.

Such actions may result in federal consequences, including remedies established by the National Labor Relations Board.

Local 27 has replaced workers at The Apothecarium in Salisbury since fall 2024. Since organizing, workers have been working for a first-ever union contract that guarantees fair wages, workplace protections, and the dignity and respect every worker deserves.

Instead of negotiating in good faith, TerrAscend has wasted thousands of dollars on a professional anti-union law firm in an effort to delay and deny these workers a fair contract. These are resources that could have been used to improve workers’ wages, benefits and working conditions.

The company’s financial track record highlights the wrong priorities. TerrAscend’s stock, which once traded for more than $15 per share, is now around $0.69 per share and is down about $0.30 this year. Despite this decline, the company continues to invest in antagonizing its workers rather than working toward a fair cooperative agreement.

Local 27 remains positive about the prospects of concluding negotiations with the company in the coming weeks and securing a first fair contract for workers at the Salisbury location.

“Federal law is federal law,” said Local 27 President Jason Chorpenning. “Workers have the right to organize without interference, intimidation or retaliation. These workers have stood together, exercised their rights, and are demanding a fair contract and basic respect. We will not tolerate violations of those rights.”

Local 27 emphasized that it will continue to aggressively defend the rights of its members and ensure that employers are held accountable under federal labor law.

For more information:
UFCW
www.ufcw.org

Continue Reading

Cannabis News

Florida Republican Governor Candidates Are United In Opposing Marijuana Legalization

Published

on

By

“I don’t support recreational marijuana. I think the current regulatory system around medicinal use is fine.”

Author: Mitch Perry, Phoenix, Florida

the subject of Should Florida legalize recreational cannabis? Smart & Safe Florida, the organization behind the initiative to return to voters this November, disappeared as a major campaign issue earlier this year after falling short of the nearly 880,000 verified petition signatures needed to qualify for the statewide ballot.

That defeat came a year and a half after nearly 56 Floridians voted to legalize recreational marijuana on the November 2024 ballot, a clear majority but far short of the 60 percent needed for passage.

While it’s not something voters will decide this year, Floridians may want to know where the candidates for statewide office stand.

Speaking at a “Business Women for Byron” campaign event Tuesday at the Getaway, a waterfront restaurant and Tiki bar in St. Petersburg, the first question an audience member asked GOP gubernatorial candidate Byron Donalds was his stance on the issue.

“I don’t condone recreational marijuana,” Donalds responded. “I think the current regulatory system around drug use is fine.”

Donalds has previously admitted to being arrested for possession of “a dime bag of marijuana” as a teenager, and recently admitted to CBS Miami he actually sold small amounts of cannabis in his youth.

Now he says he doesn’t support expanding legal weed use beyond the 924,820 Floridians listed as medical marijuana patients, according to the Office of Medical Marijuana Use.

Acceptance in medicine, but never for entertainment

Other Republicans running for governor share Donalds’ sentiments.

“I am against recreational marijuana in Florida,” investment firm CEO James Fishback told the Phoenix in a text message. “I’ve seen what it’s done in cities that have already tried it, from New York to Chicago to Washington DC. The stench of pot in public parks and outside our schools can never reach Florida.”

However, Fishback says he will always protect “the right of those who have a legitimate medical purpose, including our U.S. military veterans.”

“No one should be denied herbal medicine and pushed toward an addictive prescription from big pharma for painkillers,” she said. “As governor, I will support medical marijuana. But I won’t allow champs to smoke pot in a public park, just like we already don’t allow them to drink in one.”

“I’ve been clear from day one. I am totally opposed to legalizing marijuana,” Gov. Jay Collins said in a video posted on social media on April 26. “We’ve seen the impact in other states, and it’s not where Florida is headed. I’m with Governor DeSantis on this one. No compromise, and no money from the marijuana industry. That’s all my opponents can say.”

“I’m against recreational marijuana,” former House Speaker Paul Renner said Wednesday at a panel discussion on high energy prices in Hillsborough County.

“We have medical. It was put in the Constitution (in 2016). If people want to get it, they can get it. And we opened that up as much as needed, but I’m against recreation. Period. If it goes back to the ballot, like Gov. DeSantis did.”

DeSantis announced in June 2024 that he would use a political action committee to fight the constitutional amendment on recreational marijuana, saying he could not believe the Florida Supreme Court had agreed to allow the measure’s language to go on the November ballot.

He later used tens of millions of taxpayer dollars to campaign against that proposal and another measure that would have guaranteed abortion rights in Florida, according to a Tampa Bay Times report.

Where are the Democrats?

Phoenix caught up with the two top Democrats running for governor this year: former GOP U.S. Rep. David Jolly and Orange County Mayor Jerry Demings.

“I think the role of the governor is to represent the majority of the state, and the majority of the state asked for it, and I think we should,” Jolly told the Phoenix in a phone call Tuesday.

The Pinellas County Democrat says he voted against Amendment 3 in 2024, which would have called for the legalization of recreational marijuana use for adults.

But since announcing his candidacy last year, Jolly has emphasized that he will work to implement all of the recent constitutional amendments that have been approved by a majority in Florida, but have failed to reach the high margin of 60 percent needed to take advantage.

Recreational marijuana received more than 50 percent of the vote in the constitutional amendment process and I would support enactment and introduce any amendment that received more than 50 percent of the vote in the legislature. That includes open primaries, recreational marijuana, and the 4th Amendment on reproductive freedom,” he said.

The only major gubernatorial candidate Phoenix couldn’t clear was Demings. While serving as Orlando’s police chief in the 2010s, Demings opposed constitutional amendments that would have legalized medical marijuana. 2014 and 2016

The Phoenix reached out to the Demings campaign by phone and email for two days this week, but did not receive a response. Calls to the phone number listed in the latest press release from the Demings campaign were answered by a recording that the person with the number did not have a voice mail system set up.

President Trump passed the 3rd Amendment

One prominent Florida Republican who supported the 3rd Amendment in 2024 was President Donald Trump.

“As I’ve said before, I believe it’s time to end the unnecessary arrests and incarcerations of adults for small amounts of marijuana for personal use. We also need to put smart rules in place, giving adults access to a safe and tested product,” Trump posted on Truth Social in September 2024. “Like Florida, I will vote YES on Amendment 3 in November.”

In that position, the president promised to work to make marijuana a Schedule I drug under the Controlled Substances Act if elected to the White House, which he did in an executive order in December.

The US Department of Justice announced last month that it would immediately move FDA-approved marijuana products, along with items regulated by a state medical marijuana license, under Title III. Medical cannabis falls under the category of controlled drugs that have a recognized medical use, such as Tylenol, and not Schedule I drugs, such as heroin and LSD, which have no medical use and a high potential for abuse.

This story was first published by the Florida Phoenix.

user photo Philip Steffan.

Marihuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Planet 13 announces new appointments to Board of Directors

Published

on

By

Planet 13 Holdings has appointed the Honorable Nancy Saitta and Leilani Bradford as independent directors, filling two newly created seats on the Board, effective April 24, 2026. Justice Saitta brings two decades of judicial experience, including service as Chief Justice of the Nevada Supreme Court. Ms. Bradford brings over 20 years of real estate financing and transaction structuring experience. Both appointments broaden the Board’s independent representation and deepen governance, law enforcement and real estate. Both directors have been appointed to the Audit Committee, the Compensation Committee and the Corporate Governance and Nomination Committee.

“Justice Saitta brings a depth of judicial and governance experience that few public company boards have direct access to,” said Bob Groesbeck, co-chairman and co-CEO of Planet 13. “His 20 years on the Nevada bench, including leadership on the state’s highest court, will strengthen our oversight as we operate in an industry where regulatory rigor and disciplined decision making are essential.”

“As a Las Vegas company, we are proud to welcome two outstanding members of our local community to the Board,” said Larry Scheffler, co-chairman, CEO and co-founder of Planet 13. “Ms. Bradford has spent more than two decades building a reputation for Las Vegas real estate, structuring complex transactions and developing innovative financial disciplines that will continue to directly improve our financial growth and transaction models. opportunities.”

© Planet 13

Judge Saitta served as a member of the Nevada Judiciary for 20 years, including from 2007 to 2016 and from 2007 to 2016 and from 2011 to 2012. from 1996 to 1998. Earlier in his career, he served as the Nevada State Attorney General and Children’s Advocate and practiced law in private practice. Since 2017, Saitta has served with Advanced Justice Resolution Management as a mediator, arbitrator, special master, consultant and private judge, and continues as a senior district judge for the Nevada Supreme Court. Justice Saitta received her JD from Wayne State University School of Law and her BA from Wayne State University.

Since 2005, Ms. Bradford has served as a principal and director of SHEQ Properties, a Las Vegas-based real estate company. While at SHEQ, he has played a key role in the sourcing, underwriting and structuring of transactions, particularly in the medical and professional property sectors, and developing the company’s Shared Equity Model, which provides ownership options to physicians and service providers in connection with long-term lease agreements. Prior to joining SHEQ, Ms. Bradford had a career in accounting and finance. He is a Certified Public Accountant and earned a Bachelor of Science in Accounting from the University of Nevada, Reno.

For more information:
Planet 13
(email protected)
planet13lasvegas.com

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media